CLIA · CAP · GLP · GCLP

Testing Services

Clinical trial, LDT and GxP testing at PacificDx, our CLIA-certified, CAP-accredited high-complexity laboratory in Irvine, California, backed by the team that develops and validates the assays.

Testing menu

One laboratory for every stage of your program

Choose from validated methods, or have us develop and validate an assay for your study.

icon lab beaker

Next-generation sequencing

Targeted panels, TSO 500, RNA-Seq, exome and genome sequencing with validated bioinformatics.

Beaker icon

qPCR & ddPCR

Gene expression, copy number, viral load, vector copy number and rare-mutation detection.

icon magnify glass

Flow cytometry

Custom CLIA and GLP panels for immunophenotyping, immune monitoring and receptor occupancy.

Checklist and beaker icon

Liquid biopsy

ctDNA and cfDNA testing, including TSO 500 ctDNA, for oncology trials and diagnostic development.

Checklist and calculator icon

Immunoassays, PK & immunogenicity

ELISA, pharmacokinetic and neutralizing and total antibody (NAb/TAb) assays for nonclinical and clinical studies.

icon cogs turning

Exosome analysis

EXO-NET pan-exosome capture from plasma, serum, urine and saliva for biomarker studies.

Preclinical & clinical testing

Testing under GxP or CLIA

Assays for biopharma and gene therapy programs, run to the quality standard your study requires.

Beaker icon

Immunogenicity

Neutralizing and total antibody (NAb/TAb) assays.

Checklist and calculator icon

Pharmacokinetics

PK assays for nonclinical and clinical studies.

icon magnify glass

Immune monitoring

Immune monitoring by flow cytometry.

Checklist and beaker icon

Sensitive analyte measurement

Enzyme-linked immunosorbent assays (ELISAs).

icon lab beaker

Gene therapy biodistribution

Viral vector tissue distribution by ddPCR and qPCR.

icon cogs turning

Gene editing

Editing accuracy and specificity assessed by NGS.

Testing programs

Testing to the standard your study requires

Clinical trials

Clinical trial testing

Central and specialty laboratory testing for sponsors, with sample kits, logistics, project management and data delivery.

LDT

Laboratory-developed tests

Development, CLIA validation and launch of LDTs in our laboratory, with support for MolDX submissions and billing.

GxP

GLP and GCLP studies

Preclinical and clinical studies run under GLP or GCLP, including PK, immunogenicity and biodistribution.

Proprietary

Proprietary testing

Confidential workflows for assays validated for a single sponsor’s exclusive use.

Samples

Sample services

PBMC processing, nucleic acid extraction and compliant biorepository storage with chain of custody.

Not sure where to start?

Tell us about your samples, volumes and timelines, and we will recommend a testing plan.

Credentials

Licensed to accept specimens across the US

PacificDx holds federal CLIA certification and CAP accreditation for high-complexity testing, plus clinical laboratory licenses in California, New York, Pennsylvania and Rhode Island.

Our quality system is certified to ISO 13485:2016, and we support supplier audits and quality agreements for sponsors and diagnostic partners.

See our licenses and accreditations →

Laboratory-developed tests

Choose a laboratory with FDA experience for your LDT

In March 2025 a federal court vacated FDA’s 2024 rule on laboratory-developed tests, and FDA formally removed it in September 2025. LDTs continue to be overseen under CLIA, along with accreditors and some states.

Because our team also prepares FDA submissions, your LDT is built so it can move to a 510(k), De Novo, or PMA later if your commercial strategy calls for it.

Source: AABB, FDA Formally Vacates LDT Final Rule.

Let’s plan your testing.

Share your study design, sample volume and timelines, and we will put together a testing plan and quote.